List of Tables
Table 1. HPV Therapeutic Vaccines Market Trends
Table 2. HPV Therapeutic Vaccines Market Drivers & Opportunity
Table 3. HPV Therapeutic Vaccines Market Challenges
Table 4. HPV Therapeutic Vaccines Market Restraints
Table 5. Global HPV Therapeutic Vaccines Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global HPV Therapeutic Vaccines Revenue Market Share by Company (2019-2024)
Table 7. Key Companies HPV Therapeutic Vaccines Manufacturing Base Distribution and Headquarters
Table 8. Key Companies HPV Therapeutic Vaccines Product Type
Table 9. Key Companies Time to Begin Mass Production of HPV Therapeutic Vaccines
Table 10. Global HPV Therapeutic Vaccines Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HPV Therapeutic Vaccines as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global HPV Therapeutic Vaccines Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global HPV Therapeutic Vaccines Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global HPV Therapeutic Vaccines Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global HPV Therapeutic Vaccines Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global HPV Therapeutic Vaccines Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global HPV Therapeutic Vaccines Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global HPV Therapeutic Vaccines Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global HPV Therapeutic Vaccines Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global HPV Therapeutic Vaccines Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global HPV Therapeutic Vaccines Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global HPV Therapeutic Vaccines Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global HPV Therapeutic Vaccines Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global HPV Therapeutic Vaccines Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global HPV Therapeutic Vaccines Sales Value by Region (2019-2024) & (%)
Table 27. Global HPV Therapeutic Vaccines Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions HPV Therapeutic Vaccines Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions HPV Therapeutic Vaccines Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions HPV Therapeutic Vaccines Sales Value, (2025-2030) & (US$ Million)
Table 31. Merck & Co., Inc Basic Information List
Table 32. Merck & Co., Inc Description and Business Overview
Table 33. Merck & Co., Inc HPV Therapeutic Vaccines Products, Services and Solutions
Table 34. Revenue (US$ Million) in HPV Therapeutic Vaccines Business of Merck & Co., Inc (2019-2024)
Table 35. Merck & Co., Inc Recent Developments
Table 36. GlaxoSmithKline plc Basic Information List
Table 37. GlaxoSmithKline plc Description and Business Overview
Table 38. GlaxoSmithKline plc HPV Therapeutic Vaccines Products, Services and Solutions
Table 39. Revenue (US$ Million) in HPV Therapeutic Vaccines Business of GlaxoSmithKline plc (2019-2024)
Table 40. GlaxoSmithKline plc Recent Developments
Table 41. Shanghai Bovax Biotechnology Co., Ltd. Basic Information List
Table 42. Shanghai Bovax Biotechnology Co., Ltd. Description and Business Overview
Table 43. Shanghai Bovax Biotechnology Co., Ltd. HPV Therapeutic Vaccines Products, Services and Solutions
Table 44. Revenue (US$ Million) in HPV Therapeutic Vaccines Business of Shanghai Bovax Biotechnology Co., Ltd. (2019-2024)
Table 45. Shanghai Bovax Biotechnology Co., Ltd. Recent Developments
Table 46. Profectus BioSciences, Inc. Basic Information List
Table 47. Profectus BioSciences, Inc. Description and Business Overview
Table 48. Profectus BioSciences, Inc. HPV Therapeutic Vaccines Products, Services and Solutions
Table 49. Revenue (US$ Million) in HPV Therapeutic Vaccines Business of Profectus BioSciences, Inc. (2019-2024)
Table 50. Profectus BioSciences, Inc. Recent Developments
Table 51. 2A Pharma AB Basic Information List
Table 52. 2A Pharma AB Description and Business Overview
Table 53. 2A Pharma AB HPV Therapeutic Vaccines Products, Services and Solutions
Table 54. Revenue (US$ Million) in HPV Therapeutic Vaccines Business of 2A Pharma AB (2019-2024)
Table 55. 2A Pharma AB Recent Developments
Table 56. ISA Pharmaceuticals Basic Information List
Table 57. ISA Pharmaceuticals Description and Business Overview
Table 58. ISA Pharmaceuticals HPV Therapeutic Vaccines Products, Services and Solutions
Table 59. Revenue (US$ Million) in HPV Therapeutic Vaccines Business of ISA Pharmaceuticals (2019-2024)
Table 60. ISA Pharmaceuticals Recent Developments
Table 61. Pfizer Basic Information List
Table 62. Pfizer Description and Business Overview
Table 63. Pfizer HPV Therapeutic Vaccines Products, Services and Solutions
Table 64. Revenue (US$ Million) in HPV Therapeutic Vaccines Business of Pfizer (2019-2024)
Table 65. Pfizer Recent Developments
Table 66. Sanofi Pasteur Basic Information List
Table 67. Sanofi Pasteur Description and Business Overview
Table 68. Sanofi Pasteur HPV Therapeutic Vaccines Products, Services and Solutions
Table 69. Revenue (US$ Million) in HPV Therapeutic Vaccines Business of Sanofi Pasteur (2019-2024)
Table 70. Sanofi Pasteur Recent Developments
Table 71. Serum Institute Basic Information List
Table 72. Serum Institute Description and Business Overview
Table 73. Serum Institute HPV Therapeutic Vaccines Products, Services and Solutions
Table 74. Revenue (US$ Million) in HPV Therapeutic Vaccines Business of Serum Institute (2019-2024)
Table 75. Serum Institute Recent Developments
Table 76. Emergent BioSolutions Basic Information List
Table 77. Emergent BioSolutions Description and Business Overview
Table 78. Emergent BioSolutions HPV Therapeutic Vaccines Products, Services and Solutions
Table 79. Revenue (US$ Million) in HPV Therapeutic Vaccines Business of Emergent BioSolutions (2019-2024)
Table 80. Emergent BioSolutions Recent Developments
Table 81. Astellas Pharma Basic Information List
Table 82. Astellas Pharma Description and Business Overview
Table 83. Astellas Pharma HPV Therapeutic Vaccines Products, Services and Solutions
Table 84. Revenue (US$ Million) in HPV Therapeutic Vaccines Business of Astellas Pharma (2019-2024)
Table 85. Astellas Pharma Recent Developments
Table 86. Johnson and Johnson. Basic Information List
Table 87. Johnson and Johnson. Description and Business Overview
Table 88. Johnson and Johnson. HPV Therapeutic Vaccines Products, Services and Solutions
Table 89. Revenue (US$ Million) in HPV Therapeutic Vaccines Business of Johnson and Johnson. (2019-2024)
Table 90. Johnson and Johnson. Recent Developments
Table 91. Wantai BioPharm Basic Information List
Table 92. Wantai BioPharm Description and Business Overview
Table 93. Wantai BioPharm HPV Therapeutic Vaccines Products, Services and Solutions
Table 94. Revenue (US$ Million) in HPV Therapeutic Vaccines Business of Wantai BioPharm (2019-2024)
Table 95. Wantai BioPharm Recent Developments
Table 96. INOVIO Pharmaceuticals Basic Information List
Table 97. INOVIO Pharmaceuticals Description and Business Overview
Table 98. INOVIO Pharmaceuticals HPV Therapeutic Vaccines Products, Services and Solutions
Table 99. Revenue (US$ Million) in HPV Therapeutic Vaccines Business of INOVIO Pharmaceuticals (2019-2024)
Table 100. INOVIO Pharmaceuticals Recent Developments
Table 101. Key Raw Materials Lists
Table 102. Raw Materials Key Suppliers Lists
Table 103. HPV Therapeutic Vaccines Downstream Customers
Table 104. HPV Therapeutic Vaccines Distributors List
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
Table 108. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. HPV Therapeutic Vaccines Product Picture
Figure 2. Global HPV Therapeutic Vaccines Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global HPV Therapeutic Vaccines Sales Value (2019-2030) & (US$ Million)
Figure 4. HPV Therapeutic Vaccines Report Years Considered
Figure 5. Global HPV Therapeutic Vaccines Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by HPV Therapeutic Vaccines Revenue in 2023
Figure 7. HPV Therapeutic Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Bivalent HPV vaccine Picture
Figure 9. Quadrivalent HPV vaccine Picture
Figure 10. Global HPV Therapeutic Vaccines Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 11. Global HPV Therapeutic Vaccines Sales Value Market Share by Type, 2023 & 2030
Figure 12. Product Picture of Man
Figure 13. Product Picture of Woman
Figure 14. Global HPV Therapeutic Vaccines Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 15. Global HPV Therapeutic Vaccines Sales Value Market Share by Application, 2023 & 2030
Figure 16. North America HPV Therapeutic Vaccines Sales Value (2019-2030) & (US$ Million)
Figure 17. North America HPV Therapeutic Vaccines Sales Value by Country (%), 2023 VS 2030
Figure 18. Europe HPV Therapeutic Vaccines Sales Value (2019-2030) & (US$ Million)
Figure 19. Europe HPV Therapeutic Vaccines Sales Value by Country (%), 2023 VS 2030
Figure 20. Asia Pacific HPV Therapeutic Vaccines Sales Value (2019-2030) & (US$ Million)
Figure 21. Asia Pacific HPV Therapeutic Vaccines Sales Value by Country (%), 2023 VS 2030
Figure 22. South America HPV Therapeutic Vaccines Sales Value (2019-2030) & (US$ Million)
Figure 23. South America HPV Therapeutic Vaccines Sales Value by Country (%), 2023 VS 2030
Figure 24. Middle East & Africa HPV Therapeutic Vaccines Sales Value (2019-2030) & (US$ Million)
Figure 25. Middle East & Africa HPV Therapeutic Vaccines Sales Value by Country (%), 2023 VS 2030
Figure 26. Key Countries/Regions HPV Therapeutic Vaccines Sales Value (%), (2019-2030)
Figure 27. United States HPV Therapeutic Vaccines Sales Value, (2019-2030) & (US$ Million)
Figure 28. United States HPV Therapeutic Vaccines Sales Value by Type (%), 2023 VS 2030
Figure 29. United States HPV Therapeutic Vaccines Sales Value by Application (%), 2023 VS 2030
Figure 30. Europe HPV Therapeutic Vaccines Sales Value, (2019-2030) & (US$ Million)
Figure 31. Europe HPV Therapeutic Vaccines Sales Value by Type (%), 2023 VS 2030
Figure 32. Europe HPV Therapeutic Vaccines Sales Value by Application (%), 2023 VS 2030
Figure 33. China HPV Therapeutic Vaccines Sales Value, (2019-2030) & (US$ Million)
Figure 34. China HPV Therapeutic Vaccines Sales Value by Type (%), 2023 VS 2030
Figure 35. China HPV Therapeutic Vaccines Sales Value by Application (%), 2023 VS 2030
Figure 36. Japan HPV Therapeutic Vaccines Sales Value, (2019-2030) & (US$ Million)
Figure 37. Japan HPV Therapeutic Vaccines Sales Value by Type (%), 2023 VS 2030
Figure 38. Japan HPV Therapeutic Vaccines Sales Value by Application (%), 2023 VS 2030
Figure 39. South Korea HPV Therapeutic Vaccines Sales Value, (2019-2030) & (US$ Million)
Figure 40. South Korea HPV Therapeutic Vaccines Sales Value by Type (%), 2023 VS 2030
Figure 41. South Korea HPV Therapeutic Vaccines Sales Value by Application (%), 2023 VS 2030
Figure 42. Southeast Asia HPV Therapeutic Vaccines Sales Value, (2019-2030) & (US$ Million)
Figure 43. Southeast Asia HPV Therapeutic Vaccines Sales Value by Type (%), 2023 VS 2030
Figure 44. Southeast Asia HPV Therapeutic Vaccines Sales Value by Application (%), 2023 VS 2030
Figure 45. India HPV Therapeutic Vaccines Sales Value, (2019-2030) & (US$ Million)
Figure 46. India HPV Therapeutic Vaccines Sales Value by Type (%), 2023 VS 2030
Figure 47. India HPV Therapeutic Vaccines Sales Value by Application (%), 2023 VS 2030
Figure 48. HPV Therapeutic Vaccines Industrial Chain
Figure 49. HPV Therapeutic Vaccines Manufacturing Cost Structure
Figure 50. Channels of Distribution (Direct Sales, and Distribution)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
